CRESCENT BIOPHARMA, INC. - COMMON STOCK (CBIO) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
CBIO on Nasdaq
Shares outstanding
27,556,760
Price per share
$11.05
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
2,255,087
Total reported value
$26,717,586
% of total 13F portfolios
0%
Share change
-169,732
Value change
-$2,049,740
Number of holders
23
Price from insider filings
$11.05
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CRESCENT BIOPHARMA, INC. - COMMON STOCK (CBIO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Fairmount Funds Management LLC 19% -7.3% $73,252,396 +$32,700,021 5,643,482 +81% Fairmount Funds Management LLC 04 Dec 2025
FMR LLC 15% $49,932,849 4,133,514 FMR LLC 31 Dec 2025
ForGrowth III PA B.V. 6.1% $21,778,519 1,677,852 ForGrowth III PA B.V. 08 Dec 2025
BIOTECHNOLOGY VALUE FUND L P 10% $18,736,150 1,387,863 BVF PARTNERS L P/IL 30 Jun 2025
TANG CAPITAL MANAGEMENT LLC 5% $8,785,000 700,000 TANG CAPITAL MANAGEMENT, LLC 02 Oct 2025
Logos Global Management LP 4.1% $7,762,500 575,000 Logos Global Management LP 30 Jun 2025

As of 31 Dec 2025, 23 institutional investors reported holding 2,255,087 shares of CRESCENT BIOPHARMA, INC. - COMMON STOCK (CBIO). This represents 8.2% of the company’s total 27,556,760 outstanding shares.

Institutional Holders of CRESCENT BIOPHARMA, INC. - COMMON STOCK (CBIO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,255,087 $26,717,586 -$2,049,740 $11.86 23
2025 Q3 11,318,865 $134,581,435 +$2,899,492 $11.89 40
2025 Q2 10,751,740 $173,532,467 +$173,532,402 $16.14 29